To compare the clinicopathological features of pancreatic intraepithelial neoplasias(PanINs) and intraductal papillary mucinous neoplasms (IPMNs), and to investigate the role of hsa-miR-96 and hsa-miR-217 in these two lesions. | Hsa-miR-96 and hsa-miR-217 expression downregulates with increasing dysplasia in pancreatic intraepithelial neoplasias and intraductal papillary mucinous neoplasms